Ba da daɗewa ba Za a Amince da Alurar COVID na Pfizer ga Yara 'Yan Kasa da Shekaru 12

Wadatacce

• Bita don

Satumba yana nan kuma tare da shi, wata shekara ta makaranta da cutar ta COVID-19 ta shafa. Wasu ɗalibai sun koma aji don koyan cikakken lokaci a cikin mutum, amma har yanzu akwai damuwar da ke ci gaba da kamuwa da cututtukan coronavirus, idan aka yi la’akari da yadda lamura suka ƙaru a cikin ƙasa a lokacin bazara, a cewar bayanai daga Cibiyoyin Kula da Cututtuka da Cututtuka.Abin godiya, ba da daɗewa ba za a iya samun wuri mai haske ga iyalai masu ƙananan yara, waɗanda har yanzu ba su cancanci samun allurar COVID-19 ba: Jami'an kiwon lafiya sun tabbatar kwanan nan cewa masu yin allurar Pfizer-BioNTech suna shirin neman izini don allurar kashi biyu don amfani ga yara tsakanin shekarun 5 zuwa 11 a cikin makonni.

A wata hira da aka yi da jaridar Jamus kwanan nan Der Spiegel, Özlem Türeci, M.D., babban likitan BioNTech, ya ce, "za mu gabatar da sakamakon bincikenmu kan yara masu shekaru 5 zuwa 11 ga hukumomi a duniya cikin makwanni masu zuwa" domin samun amincewa. Dokta Türeci ya ce masu yin allurar rigakafin Pfizer-BioNTech suna shirye-shiryen yin ƙananan allurai na alluran rigakafin ga yara masu shekaru 5 zuwa 11 yayin da suke tsammanin amincewa a hukumance, a cewar Jaridar New York Times. (Kara karantawa: Yaya Allurar COVID-19 take da inganci?)

A halin yanzu, maganin Pfizer-BioNTech shine kawai maganin coronavirus da Hukumar Abinci da Magunguna ta amince da ita ga waɗanda shekarunsu suka wuce 16 zuwa sama. Ana samun allurar rigakafin Pfizer-BioNTech don ba da izinin amfani da gaggawa ga yara tsakanin shekaru 12 zuwa 15. Wannan yana nufin, duk da haka, yara 'yan ƙasa da shekaru 12 sun kasance masu rauni ga yiwuwar kamuwa da cutar. (ICYDK: Likitoci kuma suna ganin tashin hankali na masu juna biyu da ke fama da rashin lafiya tare da COVID-19.)

A lokacin bayyanar Lahadi akan CBS' Fuskanci Al'umma, Scott Gottlieb, M.D., tsohon shugaban FDA, ya ce ana iya amincewa da allurar Pfizer-BioNTech ga yara masu shekaru 5 zuwa 11 a Amurka a karshen watan Oktoba.

Dokta Gottlieb, wanda a halin yanzu yana aiki a kwamitin gudanarwa na Pfizer, ya raba cewa kamfanin magunguna zai kuma sami bayanai daga gwajin allurar rigakafi tare da yara a cikin shekaru 5 zuwa 11 a ƙarshen Satumba. Dokta Gottlieb kuma yana tsammanin za a shigar da bayanan tare da FDA "cikin sauri" - a cikin kwanaki - sannan hukumar za ta yanke shawara ko ta ba da izinin allurar rigakafin ga yara tsakanin shekarun 5 zuwa 11 a cikin makwanni.

"A cikin mafi kyawun yanayin, idan aka ba da wannan lokacin da suka tsara, za ku iya samun allurar rigakafin ga yara masu shekaru 5 zuwa 11 da Halloween," in ji Dokta Gottlieb. "Idan komai ya yi kyau, kunshin bayanan Pfizer yana cikin tsari, kuma FDA a ƙarshe ta yanke shawara mai kyau, Ina da kwarin gwiwa ga Pfizer dangane da bayanan da suka tattara. Amma wannan da gaske ya rage ga Hukumar Abinci da Magunguna. don yin manufa ta haƙiƙa." (Kara karantawa: Alluran COVID-19 na Pfizer shine farkon wanda FDA ta amince da shi sosai)

A halin yanzu ana gudanar da gwaji don tantance amincin rigakafin Pfizer-BioNTech ga yara tsakanin shekaru 2 zuwa 5, tare da bayanai kan wadancan sakamakon da ka iya zuwa a farkon Oktoba, a cewar Dr. Gottlieb. Bugu da ari, ana sa ran bayanai kan yara masu shekaru tsakanin watanni 6 zuwa shekaru 2 a wani lokaci wannan faɗuwar.

Tare da sabbin abubuwan da suka faru akan allurar Pfizer-BioNTech, kuna iya mamakin, "me ke faruwa da sauran alluran rigakafin da Amurka ta amince da su?" To, don masu farawa, da Jaridar New York kwanan nan ya ba da rahoton cewa a cikin makon da ya gabata, Moderna ya kammala nazarin gwajin gwaji ga yara masu shekaru 6 zuwa 11, kuma ana sa ran za a shigar da izini don amfani da gaggawa na FDA don wannan rukunin shekaru a ƙarshen shekara. Har ila yau, Moderna yana tattara bayanai game da yara 'yan ƙasa da shekaru 6 kuma yana tsammanin za a shigar da izini daga FDA a farkon 2022. Game da Johnson & Johnson, ya fara gwajin gwaji na asibiti guda uku a cikin matasa masu shekaru 12 zuwa 17 kuma yana shirin fara gwaji. akan yara yan kasa da shekaru 12 bayan haka.

Ga iyayen da ke cikin fargaba game da ba wa 'ya'yansu sabuwar riga-kafi, Dokta Gottlieb ya ba da shawarar tuntuɓar likitocin yara, yana ƙara da cewa iyaye ba sa fuskantar "yanke shawara" na ko za su yi wa 'ya'yansu rigakafin COVID-19 ko a'a. (Dangane da: Dalilai 8 da iyaye basa yiwa allurar rigakafi (kuma me yasa yakamata))

"Akwai [da] hanyoyi daban-daban don tunkarar rigakafin," in ji Dokta Gottlieb a kan Fuskanci Al'umma. "Kuna iya tafiya tare da kashi ɗaya a yanzu. Kuna iya jira don samun ƙananan maganin rigakafi, kuma wasu likitocin yara na iya yanke wannan hukunci. Idan yaronku ya riga ya sami COVID, kashi ɗaya na iya isa. Kuna iya yin sararin allurai. fiye."

Wannan shine kawai a ce, "akwai hankali da yawa cewa likitocin yara za su iya motsa jiki, suna yin hukunci mai yawa, amma yin amfani da hankali a cikin abin da yaron yaro yake bukata, hadarin su, da kuma abin da iyaye suke damu." in ji Dokta Gottlieb.

Lokacin da allurar rigakafin ta kasance ga waɗanda ke ƙasa da shekaru 12, tuntuɓi likitan ɗanku ko ma'aikatan kiwon lafiya don ganin zaɓinku da mafi kyawun matakin yin allurar rigakafin kananunku akan COVID-19.

Bayanai a cikin wannan labarin daidai ne har zuwa lokacin da ake bugawa. Yayin da sabuntawa game da coronavirus COVID-19 ke ci gaba da haɓaka, yana yiwuwa wasu bayanai da shawarwari a cikin wannan labarin sun canza tun farkon bugawa. Muna ƙarfafa ku da ku bincika akai-akai tare da albarkatu kamar CDC, WHO, da sashin kula da lafiyar jama'a na gida don ƙarin sabbin bayanai da shawarwari.

Bita don